SCHEMBL23337668

SCHEMBL23337668

OC(c1ccccc1)C(I)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
ADRA2C P18825 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ADRA2A P08913 1/20 0.50
HIF1A Q16665 1/20 0.50
ALDH1A1 P00352 3/20 0.48
AOC3 Q16853 6/20 0.46
CHRM2 P08172 1/20 0.46
ADRA1A P35348 1/20 0.46
RGS12 O14924 1/20 0.46
GLA P06280 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
PKM P14618 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
ALOX12 P18054 1/20 0.46
NFKB1 P19838 1/20 0.46
HTR2A P28223 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13070538 1.00 LMNA (0.50) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL3227535 0.81 LMNA (0.44) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL4608564 0.81 LMNA (0.52) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL915218 0.80 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL29674753 0.80 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL1711563 0.80 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL3055513 0.80 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL11721312 0.80 DPP4 (0.47) LMNACYP2D6TSHRHTR2ASLC6A2
SCHEMBL2889714 0.80 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A
SCHEMBL1417856 0.80 LMNA (0.62) LMNAADRA2CKDM4EADRA2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021081677-A1 CHIRAL GUANIDINES, SALTS THEREOF, METHODS OF MAKING CHIRAL GUANIDINES AND SALTS THEREOF, AND USES OF CHIRAL GUANIDINES AND SALTS THEREOF IN THE PREPARATION OF ENANTIOMERICALLY PURE AMINO ACIDS FU RUI (CA) 2021-05-06 WO disclosed